Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas

Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas

Despite the global interest and the unprecedented number of scientific studies triggered by the COVID-19 pandemic, few data are available from developing and low-income countries. In these regions, communities live under the threat of various transmissible diseases aside from COVID-19, including mal...

Full description

Bibliographic Details
Main Authors: Abdouramane Traoré, Merepen A. Guindo, Drissa Konaté, Bourama Traoré, Seidina A. Diakité, Salimata Kanté, Assitan Dembélé, Abdourhamane Cissé, Nathan C. Incandela, Mamoudou Kodio, Yaya I. Coulibaly, Ousmane Faye, Andrey V. Kajava, Federico Pratesi, Paola Migliorini, Anna Maria Papini, Lorenzo Pacini, Paolo Rovero, Fosca Errante, Mahamadou Diakité, Myriam Arevalo-Herrera, Socrates Herrera, Giampietro Corradin, Saidou Balam
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2 S protein
seroreactivity
COVID-19 samples
cross-reactivity
Pre-COVID-19 samples
malaria endemic-area
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.856033/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.856033/full

Similar Items